Emmanuel Vincent, our CEO, will be attending the JP Morgan 43rd Annual Healthcare Conference in San Francisco, CA, USA, from 13 to 16 January.

Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for research, clinical, and industrial applications.

Take the opportunity to meet Emmanuel and find out how we’re leading the way in bioproduction innovation!